Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy

Journal of the American College of Surgeons

Volumn 197, Issue 2, 2003, Pages 254-260

  Koda, Keiji ^a   Saito, Norio ^b   Oda, Kenji ^a   Seike, Kazuhiro ^a   Kondo, Eisuke ^a   Ishizuka, Mitsuru ^a   Takiguchi, Nobuhiro ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TEGAFUR;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE COURSE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; RECTUM CANCER; RISK FACTOR;

EID: 0041665067     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(03)00115-7     Document Type: Article

References (16)

1. Koda K, Saito N, Takiguchi N, et al. Preoperative natural killer cell activity - correlation with distant metastases in curatively resected colorectal carcinomas. Int Surg 1997;82:190-193.
2. Colon and rectum. In: American Joint Committee on Cancer: AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott Raven Publishers; 1997:83-90.
3. Abo T. Natural killer cell activity. Jpn J Clin Med 1990;48:726-729.
4. Saito N, Sarashina H, Nunomura M, et al. Clinical evaluation of nerve-sparing surgery combined with preoperative radiotherapy in advanced rectal cancer patients. Am J Surg 1998;175:277-282.
5. Onoda JM, Kantak SS, Piechocki MP, et al. Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenese inhibitor. Radiat Res 2001;140:410-418.
6. Molla M, Panes J, Casadevall M, et al. Influence of dose-rate on inflammatory damage and adhesion molecule expression after abdominal radiation in the rat. Int J Radiat Oncol Biol Phys 1999;45:1011-1018.
7. Yamazaki H, Yoshioka Y, Inoue T, et al. Changes in natural killer cell activity by external radiotherapy and/or brachytherapy. Oncol Rep 2002;9:359-363.
8. Harrington NP, Chambers KA, Ross WM, et al. Radiation damage and immune suppression in splenic mononuclear cell populations. Clin Exp Immmunol 1997;107:417-424.
9. Shpitz B, Fernandes BJ, Mullen JB, et al. Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialoGM1. Anticancer Res 1994;14:1927-1934.
10. Aboud M, Kingsmore S, Segal S. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones. Nat Immun 1993;12:17-24.
11. Kim S, Iizuka K, Aguila HL, et al. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 2000;97:2731-2736.
12. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999;80:880-888.
13. Smyth MJ, Thia KY, Cretney E, et al. Perforin is a major contributor to NK cell control of tumor metastases. J Immunol 1999;162:6658-6662.
14. Ahmad NR, Nagle D. Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 1997;84:1445-1448.
15. Frykholm GJ, Pahlman L, Glimelius B. Treatment of local recurrence of rectal carcinoma. Radiother Oncol 1995;34:185-194.
16. Luna-Perez P, Trejo-Valdivia B, Labastida S, et al. Prognostic factors in patients with locally advanced rectal adenocarcinoma treated with preoperative radiotherapy and surgery. World J Surg 1999;23:1069-1074.